메뉴 건너뛰기




Volumn 27, Issue 3, 2006, Pages 653-

Eradicaiton of Pseudomonas aeruginosa in cystic fibrosis patients [3]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

EID: 33644862814     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00132105     Document Type: Letter
Times cited : (9)

References (6)
  • 1
    • 23444434606 scopus 로고    scopus 로고
    • Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
    • Taccetti G, Campana S, Festini F, Mascherini M, Döring G. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005; 26: 458-461.
    • (2005) Eur Respir J , vol.26 , pp. 458-461
    • Taccetti, G.1    Campana, S.2    Festini, F.3    Mascherini, M.4    Döring, G.5
  • 2
    • 31844432588 scopus 로고    scopus 로고
    • Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
    • Eber E, Thalhammer GH, Zach MS. Eradication of Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2006; 27: 438-439.
    • (2006) Eur Respir J , vol.27 , pp. 438-439
    • Eber, E.1    Thalhammer, G.H.2    Zach, M.S.3
  • 3
    • 0034785372 scopus 로고    scopus 로고
    • Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization
    • Munck A, Bonacorsi S, Mariani-Kurkdjian P, et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol 2001; 32: 288-292.
    • (2001) Pediatr Pulmonol , vol.32 , pp. 288-292
    • Munck, A.1    Bonacorsi, S.2    Mariani-Kurkdjian, P.3
  • 4
    • 0003656124 scopus 로고    scopus 로고
    • Pseudomonas aeruginosa infection in people with cystic fibrosis. Suggestions for prevention and infection control
    • Cystic Fibrosis Trust. Bromley, Cystic Fibrosis Trust
    • Cystic Fibrosis Trust. Pseudomonas aeruginosa infection in people with cystic fibrosis. Suggestions for prevention and infection control. Bromley, Cystic Fibrosis Trust, 2001.
    • (2001)
  • 5
    • 33644861653 scopus 로고    scopus 로고
    • The role of P. aeruginosa antibodies for defining airway infection with P. aeruginosa in CF patients
    • Ratjen F, Grasemann H, Döring G. The role of P. aeruginosa antibodies for defining airway infection with P. aeruginosa in CF patients. Pediatr Pulmonol 2004; Suppl. 27: 263A.
    • (2004) Pediatr Pulmonol , Issue.SUPPL. 27
    • Ratjen, F.1    Grasemann, H.2    Döring, G.3
  • 6
    • 0037067169 scopus 로고    scopus 로고
    • Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: Early detection by serology and assessment of risk factors
    • West SE, Zeng L, Lee BL, et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 2002; 287: 2958-2967.
    • (2002) JAMA , vol.287 , pp. 2958-2967
    • West, S.E.1    Zeng, L.2    Lee, B.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.